Many Zantac Users Fear Stomach Cancer From Taking The Drug
Zantac allegedly causes many different types of cancer, but stomach cancer may be the most common
Tuesday, September 22, 2020 - The FDA and reputable drug testing companies have found Zantac and other brands of the heartburn relief drug ranitidine to contain elevated and possibly carcinogenic levels of N-nitrosodimethylamine (NDMA). Zantac (ranitidine) was always known to contain NDMA but at a level thought by the FDA to be safe. Only recently were the results of the tests made public that alleged Zantac contained levels of NDMA thousands of times greater and sparking cancer concerns. Thousands of people that have used Zantac in the past decade and have developed cancer have hired a Zantac Cancer Lawyer to file a claim for lump sum compensation due to the personal injuries they have allegedly suffered from taking Zantac. Zantac is alleged to cause a variety of deadly, painful cancer like bladder, colon, breast, and prostate cancer but most often lawsuits have focused on stomach cancer. Zantac acid reflux stomach cancer attorneys offer a free consultation and no obligation to file a claim.
Stomach cancer, also known as Gastric cancer, was the reason women from the midwest recently filed a Zantac Cancer Lawsuit against pharmaceutical giant Sanofi, the maker of Zantac. According to NewYorkLegalExaminer, "An Illinois woman recently filed a new Zantac lawsuit in the U.S. District Court for the District of New Jersey. She claims that after taking the antacid drug for years, she developed cancer, which she believes was caused by the medication. Multiple manufacturers, including Sanofi, which currently produces Zantac, have issued recalls of Zantac and generic ranitidine after tests found many of the products contained N-nitrosodimethylamine (NDMA), a probable human carcinogen." The Examiner told readers that the women took the over-the-counter drug routinely for around 18 years and followed the direction on the packaging. She developed stomach cancer in 2019 and immediately made the connection with using Zantac.
The Mayo Clinic writes extensively about the causes, symptoms, and treatments for stomach and gastric cancer, telling us that stomach cancer usually begins in the stomach's protective mucus membrane, the part of the stomach that protects its tissue from stomach acid. The rates of stomach cancer in the upper part of the stomach, the gastroesophageal junction, have been on the rise. The epidemic of obesity in North America coincides with people overeating, and when the stomach overfills, acids spill out and up into the esophagus, an organ not protected against highly corrosive stomach acid. If you have been taking the heartburn and acid reflux medicine Zantac or another form of ranitidine, you should closely self-monitor for potential signals of stomach or gastric cancer. Diagnosing and treating stomach cancer in the earliest stage is key to successfully treating the disease. You may have stomach cancer if you start to feel fatigued, bloated, easily full after eating, persistent and severe heartburn or indigestion, nausea, stomach pain, vomiting, and weight loss. Zantac and other heartburn drug victims should immediately seek medical attention at the first sign of any of these symptoms.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.